According
to a new market research report published by Transparency Market
Research "Regenerative Medicine (Bone and Joint) Market (By
Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering;
By Applications - Bone Graft Substitutes, Osteoarticular Diseases,
Allogeneic Products, Autogenic Products and Others) - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019"
the global regenerative medicine (bone and joint) market was valued
at USD 2.6 billion in 2012 and is estimated to reach a market worth
of USD 6.5 billion in 2019 growing at a CAGR of 12.8% from 2013 to
2019.
Browse
the full Regenerative Medicine Market Report
at
http://www.transparencymarketresearch.com/regenerative-medicines-market.html
Regenerative
medicine is considered as an emerging field of medical science that
aims to regenerate, repair or replace damaged tissue and organs. U.S.
National Institute of Health stated that regenerative medicine is the
process of creating functional tissue to repair and replace tissue or
organ which has lost their function due to damage, congenital
defects, disease and age. Technological advancement in tissue
engineering and stem cell therapy is expected to drive the global
market for regenerative medicine (bone and joint). Moreover, growing
prevalence of bone and joint disorder has also accounted for the
market growth of the global regenerative medicine (bone and joint)
market.
However,
ethical issues pertaining to stem cell therapy and fear of disease
transmission due to allogeneic bone implantation are considered as
market hindering factors during the study period. Companies operating
in this market focus on investing in emerging economies of
Asia-Pacific such as India, China, Japan and South Korea. These
economies represent huge potential for various bone and joint
reconstructive products due to rising healthcare expenditure and
presence of large patient pool suffering from arthritis disorder
(rheumatoid arthritis).
The
global market for regenerative medicine is segmented based on
technology as stem cell therapy, biomaterials and tissue engineering.
In 2012, biomaterials segment accounted for the largest market share
in the global regenerative medicine (bone and joint) market owing to
favorable reimbursement policies and strong demand of biomaterials in
the global market. However, high cost associated with biomaterials is
a factor that would restrict the global market demand to some extent
during the study period.
In
addition, based on applications the global market for regenerative
medicine (bone and joint) is segmented as bone graft substitute,
osteoarticular diseases, allogeneic bones, autogenic bones and
others. In 2012, bone graft substitute segment accounted for the
largest market share in the global regenerative medicine bone and
joint application market owing to growing demand of bone graft
substitute in orthopaedic surgeries. However, post implantation
rejection associated with bone graft substitute is considered as a
crucial factor that would restrict the global market demand of bone
graft substitute.
Browse
the Press Release of Regenerative Medicine Market @
http://www.transparencymarketresearch.com/pressrelease/regenerative-medicines-market.html
On
the basis of geography, the regenerative medicine (bone and joint)
market is segmented as North America, Europe, Asia-Pacific and Rest
of the World (RoW). North America accounted for the largest market
share for regenerative medicine (bone and joint) globally in 2012
owing to increase in orthopedic reconstructive surgeries and
introduction of technologically advanced medical devices and
products. According to the American Academy of Orthopedic Surgeons
(AAOS), prevalence of Lumbar Spinal Stenosis (LSS) is increasing with
rise in elderly population and is estimated that approximately 2.4
million Americans would be affected by LSS by 2021. It has also
stated that in 1990 approximately 129,000 Total Knee Arthroplasty
(TKA) surgeries were performed in the U.S. Europe accounted for the
second largest share in the global regenerative medicine (bone and
joint) market in 2012.
Large
geriatric population base is one of the important factors driving the
growth of regenerative medicine bone and joint application market in
this region. Asia-Pacific is expected to grow at the highest CAGR
from 2013 to 2019, due to large pool of potential reconstructive
surgery patients and strong support from federal government.
Additionally, companies are expecting large revenue with sufficient
market penetration from Asia-Pacific region and thereby focusing on
increasing investments in this region. For instance, in May 2013,
Smith & Nephew acquired Sushrut Surgical Pvt. Ltd. an Indian
medical technology company. Sushrut Surgicals product portfolio
includes trauma implants and instruments, spine and limb salvage
products. This acquisition would expand and enhance the product
offerings of Smith & Nephew and would also assist in capturing
lucrative market share in Asia-Pacific region.
Major
market players having presence in the global regenerative medicine
(bone and joint) market include DePuy Synthes, Inc. (HEALOS Bone
Graft), Medtronic, Inc. (INFUSE Bone Graft) and Zimmer Holdings, Inc.
(CopiOs Bone Void Filler), Orthofix, Inc. (Trinity Evolution) and
NuVasive, Inc. (Osteocel Plus).
The
global regenerative medicine (bone and joint) market is segmented as
follows:
Regenerative
Medicine (Bone and Joint) Market, by Technology
Stem
Cell Therapy
Biomaterial
Tissue
Engineering
Browse
the full Regenerative Medicine Market Report at
http://www.transparencymarketresearch.com/regenerative-medicines-market.html
Regenerative
Medicine (Bone and Joint) Market, by Application
Bone
Graft Substitutes
Osteoarticular
Diseases
Allogeneic
Bones
Autogenic
Bones
Others
Regenerative
Medicine (Bone and Joint) Market, by Geography
North
America
Europe
Asia-Pacific
Rest
of the World
Browse
All Biotechnology Market Research Reports @
http://www.transparencymarketresearch.com/biotechnology-market-reports-18.html
About
Us
Transparency
Market Research is a market intelligence company providing global
business information reports and services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking
insight for thousands of decision makers.
We
are privileged with highly experienced team of Analysts, Researchers
and Consultants, who use proprietary data sources and various tools
and techniques to gather, and analyze information. Our business
offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Contact
Transparency
Market Research
90
State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA
- Canada Toll Free 866-552-3453
No comments:
Post a Comment